Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
1992-10-26
pubmed:databankReference
pubmed:abstractText
Transforming growth factor-beta (TGF-beta) is capable of affecting the proliferation of many cell types. To identify novel genes whose protein products may mediate cellular responses to this factor, a cDNA library was made from mRNA isolated from a human lung adenocarcinoma cell line (A549) that had been treated for 3 days with TGF-beta. The library was screened by differential hybridization and a cDNA clone, beta ig-h3, was isolated. This gene was induced up to 20-fold in A549 cells after 2 days of treatment with TGF-beta 1. It was also induced in several other cell lines, including PC-3 and H2981. DNA sequence analysis of beta ig-h3 indicated that it encoded a novel protein, beta IG-H3, of 683 amino acids, which contained an amino-terminal secretory sequence and a carboxy-terminal Arg-Gly-Asp (RGD) sequence that can serve as a ligand recognition site for several integrins. beta IG-H3 also contained short amino acid regions homologous to similar regions in Drosophila fasciclin-I and four homologous internal domains, which can be folded into a potential bivalent structure and could act as a bridge between cells expressing the appropriate ligand. beta ig-h3 RNA was detected in several cell lines and tissues. COS cells transfected with plasmids encoding beta IG-H3 secreted a major 68-kD protein that was detected by immunoblotting using antipeptide antibodies. Since beta ig-h3 is induced in several cell lines whose proliferation is affected by TGF-beta 1, it may be involved in mediating some of the signals of this multifunctional growth modulator.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
1044-5498
pubmed:author
pubmed:issnType
Print
pubmed:volume
11
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
511-22
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed-meshheading:1388724-Adenocarcinoma, pubmed-meshheading:1388724-Amino Acid Sequence, pubmed-meshheading:1388724-Base Sequence, pubmed-meshheading:1388724-Cell Differentiation, pubmed-meshheading:1388724-Cell Division, pubmed-meshheading:1388724-Cell Line, pubmed-meshheading:1388724-Cloning, Molecular, pubmed-meshheading:1388724-DNA, pubmed-meshheading:1388724-Extracellular Matrix Proteins, pubmed-meshheading:1388724-Humans, pubmed-meshheading:1388724-Immunoblotting, pubmed-meshheading:1388724-Kinetics, pubmed-meshheading:1388724-Molecular Sequence Data, pubmed-meshheading:1388724-Neoplasm Proteins, pubmed-meshheading:1388724-Proteins, pubmed-meshheading:1388724-Sequence Homology, pubmed-meshheading:1388724-Transcription, Genetic, pubmed-meshheading:1388724-Transfection, pubmed-meshheading:1388724-Transforming Growth Factor beta, pubmed-meshheading:1388724-Tumor Cells, Cultured
pubmed:year
1992
pubmed:articleTitle
cDNA cloning and sequence analysis of beta ig-h3, a novel gene induced in a human adenocarcinoma cell line after treatment with transforming growth factor-beta.
pubmed:affiliation
Bristol Myers Squibb, Seattle, WA 98121.
pubmed:publicationType
Journal Article